Chi-square test results comparing clinicopathological demographics between high and low-EIF2S1-expressing NB patients showed that upregulation of EIF2S1 was positively associated with tumor stage, risk of NB, and incidence of distant metastasis (Table 2). This evidence concerns the gene EIF2S1 and neuroblastoma.